Efficacy and Safety Evaluation of Refralon®, Concentrate for Solution for Intravenous Injection in Patients With Paroxysmal and Persistent Atrial Fibrillation and Flutter
Clinical trial NCT05773170 · COMPLETED
Trial details
- NCT number
- NCT05773170
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-11
- Primary completion
- 2023-06-01
- Enrollment
- 1147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.